Early renal abnormalities in autosomal dominant polycystic kidney disease

Clinical Journal of the American Society of Nephrology

Volumn 5, Issue 6, 2010, Pages 1091-1098

  Meijer, Esther ^a   Rook, Mieneke ^a   Tent, Hilde ^a   Navis, Gerjan ^a   Van Der Jagt, Eric J ^a   De Jong, Paul E ^a   Gansevoort, Ron T ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN;

ADULT; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; KIDNEY MALFORMATION; KIDNEY PLASMA FLOW; KIDNEY POLYCYSTIC DISEASE; KIDNEY VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; URINARY EXCRETION; URINE OSMOLALITY; URINE VOLUME; ADOLESCENT; AGE; ALBUMINURIA; BLOOD PRESSURE; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; DISEASE COURSE; DOMINANT GENE; GENETICS; GENOTYPE; HEMODYNAMICS; KIDNEY; MIDDLE AGED; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; SEVERITY OF ILLNESS INDEX; URODYNAMICS; VASCULAR RESISTANCE; VASCULARIZATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; ALBUMINURIA; BLOOD PRESSURE; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; GENES, DOMINANT; GENOTYPE; GLOMERULAR FILTRATION RATE; HEMODYNAMICS; HUMANS; KIDNEY; MALE; MIDDLE AGED; ORGAN SIZE; PHENOTYPE; POLYCYSTIC KIDNEY DISEASES; RENAL PLASMA FLOW, EFFECTIVE; SEVERITY OF ILLNESS INDEX; URODYNAMICS; VASCULAR RESISTANCE; YOUNG ADULT;

EID: 77953305179     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.00360110     Document Type: Article

References (41)

1. Torres VE, Harris PC, Pirson Y: Autosomal dominant polycystic kidney disease. Lancet 369: 1287-1301, 2007
2. Stengel B, Billon S, Van Dijk PC, Jager KJ, Dekker FW, Simpson K, Briggs JD: Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe, 1990-1999. Nephrol Dial Transplant 18: 1824-1833, 2003
3. Schrier R, McFann K, Johnson A, Chapman A, Edelstein C, Brosnahan G, Ecder T, Tison L: Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: Results of a seven-year prospective randomized study. J Am Soc Nephrol 13: 1733-1739, 2002
4. van Dijk MA, Breuning MH, Duiser R, van Es LA, Westendorp RG: No effect of enalapril on progression in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 18: 2314-2320, 2003
5. Meijer E, de Jong PE, Peters DJ, Gansevoort RT: Better understanding of ADPKD results in potential new treatment options: Ready for the cure? J Nephrol 21: 133-138, 2008
6. Torres VE, Harris PC: Autosomal dominant polycystic kidney disease: The last 3 years. Kidney Int 76: 149-168, 2009
7. Cowley BD Jr: Recent advances in understanding the pathogenesis of polycystic kidney disease: Therapeutic implications. Drugs 64: 1285-1294, 2004
8. Churchill DN, Bear JC, Morgan J, Payne RH, McManamon PJ, Gault MH: Prognosis of adult onset polycystic kidney disease re-evaluated. Kidney Int 26: 190-193, 1984 (Pubitemid 14017058)
9. Franz KA, Reubi FC: Rate of functional deterioration in polycystic kidney disease. Kidney Int 23: 526-529, 1983 (Pubitemid 13117121)
10. Grantham JJ, Chapman AB, Torres VE: Volume progression in autosomal dominant polycystic kidney disease: The major factor determining clinical outcomes. Clin J Am Soc Nephrol 1: 148-157, 2006
11. Chapman AB, Guay-Woodford LM, Grantham JJ, Torres VE, Bae KT, Baumgarten DA, Kenney PJ, King BF Jr, Glockner JF, Wetzel LH, Brummer ME, O'Neill WC, Robbin ML, Bennett WM, Klahr S, Hirschman GH, Kimmel PL, Thompson PA, Miller JP: Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort. Kidney Int 64: 1035-1045, 2003
12. Gabow PA, Kaehny WD, Johnson AM, Duley IT, Manco-Johnson M, Lezotte DC, Schrier RW: The clinical utility of renal concentrating capacity in polycystic kidney disease. Kidney Int 35: 675-680, 1989 (Pubitemid 19051769)
13. Chapman AB, Johnson AM, Gabow PA, Schrier RW: Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 5: 1349-1354, 1994 (Pubitemid 24977120)
14. Rizk D, Chapman AB: Cystic and inherited kidney diseases. Am J Kidney Dis 42: 1305-1317, 2003
15. King BF, Torres VE, Brummer ME, Chapman AB, Bae KT, Glockner JF, Arya K, Felmlee JP, Grantham JJ, Guay-Woodford LM, Bennett WM, Klahr S, Hirschman GH, Kimmel PL, Thompson PA, Miller JP: Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease. Kidney Int 64: 2214-2221, 2003
16. Torres VE, King BF, Chapman AB, Brummer ME, Bae KT, Glockner JF, Arya K, Risk D, Felmlee JP, Grantham JJ, Guay-Woodford LM, Bennett WM, Klahr S, Meyers CM, Zhang X, Thompson PA, Miller JP: Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2: 112-120, 2007
17. Ravine D, Gibson RN, Walker RG, Sheffield LJ, Kincaid-Smith P, Danks DM: Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet 343: 824-827, 1994
18. Lambers Heerspink HJ, Brantsma AH, De Zeeuw D, Bakker SJ, de Jong PE, Gansevoort RT: Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortality. Am J Epidemiol 168: 897-905, 2008
19. Pinto-Sietsma SJ, Janssen WM, Hillege HL, Navis G, De Zeeuw D, de Jong PE: Urinary albumin excretion is associated with renal functional abnormalities in a nondiabetic population. J Am Soc Nephrol 11: 1882-1888, 2000
20. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470, 1999
21. Rose BD: Clinical Physiology of Acid-Base and Electrolyte Disorders, 5th Ed, New York, McGraw-Hill, 2001
22. Donker AJ, van der Hem GK, Sluiter WJ, Beekhuis H: A radioisotope method for simultaneous determination of the glomerular filtration rate and the effective renal plasma flow. Neth J Med 20: 97-103, 1977 (Pubitemid 8129523)
23. Apperloo AJ, de Zeeuw D, Donker AJ, de Jong PE: Precision of glomerular filtration rate determinations for longterm slope calculations is improved by simultaneous infusion of 125I-iothalamate and 131I-hippuran. J Am Soc Nephrol 7: 567-572, 1996
24. Michels WM, Grootendorst DC, Rozemeijer K, Dekker FW, Krediet RT: Glomerular filtration rate measurements by (125)I-iothalamate should be corrected for inaccurate urine collections with (131)I-hippuran. Clin Nephrol 72: 337-343, 2009
25. de Leeuw PW, Kho TL, Falke HE, Birkenhager WH, Wester A: Haemodynamic and endocrinological profile of essential hypertension. Acta Med Scand Suppl 622: 5-86, 1978
26. Cohen EI, Kelly SA, Edye M, Mitty HA, Bromberg JS: MRI estimation of total renal volume demonstrates significant association with healthy donor weight. Eur J Radiol 71: 283-287, 2009
27. Klein IH, Ligtenberg G, Oey PL, Koomans HA, Blankestijn PJ: Sympathetic activity is increased in polycystic kidney disease and is associated with hypertension. J Am Soc Nephrol 12: 2427-2433, 2001 (Pubitemid 33021120)
28. Navis G, de Jong PE, Donker AJ, van der Hem GK, de Zeeuw D: Moderate sodium restriction in hypertensive subjects: Renal effects of ACE-inhibition. Kidney Int 31: 815-819, 1987 (Pubitemid 17025915)
29. Dimitrakov D, Kumchev E, Lyutakova E, Grigorov L: Glomerular hyperfiltration and serum beta 2-microglobulin used as early markers in diagnosis of autosomal dominant polycystic kidney disease. Folia Med (Plovdiv) 35: 59-62, 1993
30. Wong H, Vivian L, Weiler G, Filler G: Patients with autosomal dominant polycystic kidney disease hyperfiltrate early in their disease. Am J Kidney Dis 43: 624-628, 2004
31. Bosma RJ, van der Heide JJ, Oosterop EJ, de Jong PE, Navis G: Body mass index is associated with altered renal hemodynamics in non-obese healthy subjects. Kidney Int 65: 259-265, 2004
32. Rook M, van der Heide JJ, Navis G: Significant negative association with age and both GFR and ERPF in male and female living kidney donors. Nephrol Dial Transplant 22: 283, 2007
33. Kriz W, LeHir M: Pathways to nephron loss starting from glomerular diseases - Insights from animal models. Kidney Int 67: 404-419, 2005
34. Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM: Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation. Am J Physiol 241: F85-F93, 1981
35. Brenner BM, Meyer TW, Hostetter TH: Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 307: 652-659, 1982
36. Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM: Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation. J Am Soc Nephrol 12: 1315-1325, 2001
37. Bosma RJ, Kwakernaak AJ, van der Heide JJ, de Jong PE, Navis GJ: Body mass index and glomerular hyperfiltration in renal transplant recipients: Cross-sectional analysis and long-term impact. Am J Transplant 7: 645-652, 2007
38. Gansevoort RT, De Zeeuw D, de Jong PE: ACE inhibitors and proteinuria. Pharm World Sci 18: 204-210, 1996
39. Heeg JE, de Jong PE, van der Hem GK, De Zeeuw D: Reduction of proteinuria by angiotensin converting enzyme inhibition. Kidney Int 32: 78-83, 1987 (Pubitemid 17094501)
40. Zeltner R, Poliak R, Stiasny B, Schmieder RE, Schulze BD: Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 23: 573-579, 2008
41. Chapman AB: Approaches to testing new treatments in autosomal dominant polycystic kidney disease: Insights from the CRISP and HALT-PKD studies. Clin J Am Soc Nephrol 3: 1197-1204, 2008